Back to search

University of Crete (UOC)

The role of apolipoprotein A-I in the atheroprotective functions of high-density lipoprotein (HDL)

Abstract

dc:description

Numerous epidemiological and clinical studies have demonstrated an inverse correlation between plasma high-density lipoprotein (HDL) cholesterol levels and the risk for coronary heart disease in humans. Apolipoprotein A-I (apoA-I) constitutes the major protein component of HDL and possesses a central role in HDL biogenesis, structure and function. ApoA-I interacts with several receptors and enzymes (ABCA1, ABCG1, SR-BI, LCAT) that participate in HDL metabolism and functions. The above interactions lead to the activation of atheroprotective mechanisms such as cholesterol efflux, maintenance of endothelial integrity as well as mechanisms involving anti-oxidative, anti-inflammatory and anti-apoptotic actions. The aim of this PhD thesis was to study the role of apoA-I in the anti-inflammatory and atheroprotective functions of HDL in vivo.Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that is associated with increased cardiovascular morbidity and mortality. In addition, low HDL cholesterol levels are considered a marker for various chronic inflammatory conditions, while the levels of pro-inflammatory HDL are increased in RA patients. In Chapter I we studied the role of HDL in RA. For this purpose, we used a model of antigen-induced arthritis in wild-type and in apoA-I-/- mice to investigate the effect of HDL deficiency on the pathogenesis of RA as well as the effect of chronic inflammation on HDL levels and atheroprotective functions. Moreover, we assessed HDL’s ability to modulate the immune system and attenuate the inflammatory response. Following induction of arthritis, wild-type mice demonstrated moderate to severe inflammation while the majority of apoA-I-/- mice exhibited a more severe phenotype which was associated with pannus formation. In order to study the effect of HDL on Τh1 and Th17 immune responses which are implicated in RA development, the antigen-specific proliferation and differentiation of Th cells in the presence of increasing amounts of reconstituted HDL was determined in draining lymph nodes (dLNs) from ovalbumin-immunized wild-type mice. The induction and proliferation of autoreactive Τ cells was determined by measuring cytokine levels (IFN-γ, IL-17, IL-2) in culture medium. According to these results treatment of dLN cells with rHDL led to a dose-dependent suppression of cytokine secretion. Next, we studied the effect of rΗDL treatment on bone-marrow-derived dendritic cells (BMDCs) and concluded that rHDL suppressed pro-inflammatory cytokine secretion (IL-6, IL-12, IL-23, IL-8, TNF-α) and downregulated co-stimulatory molecules (CD40, CD80, CD86, MHC-II) in these cells. Finally, we showed that the suppressive effect of rHDL was attenuated in BMDCs lacking either ABCA1 or SR-BI, thus providing evidence for an important role of these two membrane lipid transporters in the HDL-mediated anti-inflammatory functions on DCs.In Chapter II we investigated the effect of two naturally occurring mutations of human apoA-I, apoA-I(L141R)Pisa and apoA-I(L159R)FIN, on HDL biogenesis and atherosclerosis development in vivo. Humans that are heterozygotes for either of these apoA-I mutations exhibit very low levels of plasma HDL cholesterol and some of them develop premature atherosclerosis.In order to study the properties of the above mutations in vivo we generated transgenic mice that express either wild-type or mutant human apoA-I in the liver. Briefly, wild-type and mutant forms of apoA-I were cloned downstream of the mouse transthyretin promoter (TTR1). The TTR1-apoA-I fragments were excised and used to inject male pronucleus of C57BL6/CBA F2 fertilized eggs for transgenesis purposes. Selected founder animals were crossed with apoA-I-/- mice to obtain human apoA-I transgenic mice on an apoA-I deficient background. The human apoA-I transgenic mice were analyzed for abnormalities in their lipid and lipoprotein profile, in HDL structure and functionality as well as for predisposition to atherosclerosis. Transgenic mice expressing either mutant apoA-I form were characterized by very low serum total and HDL-cholesterol, as well as serum apoA-I levels. Moreover, these mice generated only few small spherical HDL particles with pre-β2 and α3, α4 electrophoretic mobility. HDL particles containing either apoA-I mutant exhibited attenuated anti-oxidative properties but increased capacity to promote ABCA1-dependent cholesterol efflux and endothelial cell migration. Finally, the expression of human apoA-I(L141R)Pisa or apoA-I(L159R)FIN in mice was associated with increased diet-induced atherosclerosis compared to mice expressing wild-type apoA-I and apoA-I deficient mice.Recent studies suggest that the normally atheroprotective HDL can be rendered atherogenic as a result of the myeloperoxidase (MPO)-mediated oxidative modifications in apoA-I. It has been shown that MPO-dependent chlorination of Tyr-192 combined with oxidation of Met-148 residues of apoA-I inhibit its ability to promote ABCA1-mediated cholesterol efflux. Moreover, in vitro studies have demonstrated that oxidation of Met-148 by MPO impairs the ability of apoA-I to activate LCAT. However, the mechanisms underlying formation of dysfunctional HDL particles remain largely unknown.In Chapter III we aimed at investigating the mechanisms of apoA-I modification by MPO leading to the generation of dysfunctional HDL in vivo. For this purpose, we generated recombinant adenoviruses carrying either wild-type (apoA-I WT) or mutant forms of apoA-I [apoΑ-Ι(Met148Ala) και apoΑ-Ι(Tyr192Ala)] as well as adenovirus expressing human MPO. The above mutations in the human apoA-I gene were generated by site-directed mutagenesis, while the human MPO cDNA sequence was cloned from neutrophils isolated from human peripheral blood. All sequences were subcloned into the pAdTrack-CMV vector and recombinant adenoviruses were generated according to the AdEasy protocol, purified by CsCl gradient ultracentrifugation and titrated by performing the plaque assay. The titrated adenoviruses were used to infect cells to determine efficient production and secretion of the corresponding protein. The adenoviruses expressing the above apoA-I mutants will be used either separately or in combination with the adenovirus expressing MPO to infect apoA-I-/- mice, and allow the investigation of the in vivo effect of MPO on lipids concentration, HDL structure and functions.Genome-wide association studies have identified new genetic loci, including the GALNT2 (GalNAc Transferase 2) gene, that are associated with low HDL levels. GALNT2 is an enzyme that participates in O-glycosylation of proteins by catalyzing the transfer an N-acetyl galactosamine to serine/threonine residues. Since O-glycosylation possesses a regulatory role in protein function, it is possible that GALNT2 affects lipid concentration by modifying several of the proteins that participate in the HDL pathway.In Chapter IV we aimed at investigating the role of GALNT2 in HDL metabolism in vivo by performing adenovirus-mediated gene transfer in apoA-I transgenic mice. To this end, the sequence of human GALNT2 cDNA was cloned from HepG2 cells and then subcloned into an appropriate vector which was used to generate a recombinant adenovirus expressing GALNT2 (Ad-GALNT2) according to the AdEasy methodology. The generated adenovirus was subsequently amplified, purified and titrated as aforementioned. Adenovirus-mediated gene transfer will be performed in transgenic mice that express the human apoA-I gene under the control of its proximal promoter and enhancer in an apoA-I deficient background. Following infection, a series of analyses will be performed in order to determine serum lipids concentration, enzyme activities (LPL, LCAT) as well as HDL structure and functionality. The above experiments will provide insights on the effect of GALNT2 on HDL structure and metabolism in vivo.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tiniakou, Ioanna
  • Τηνιακού, Ιωάννα

Subjects

dc:subject × 28

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35985

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tiniakou, Ioanna; Τηνιακού, Ιωάννα. The role of apolipoprotein A-I in the atheroprotective functions of high-density lipoprotein (HDL). University of Crete (UOC), 2015. http://hdl.handle.net/10442/hedi/35985